NLRP3 and colitis: They also found that the hyperactive NLRP3 inflammasome, which led to a local over-production of IL-1β, could maintain gut homeostasis and confer a strong resistance to experimental colitis through a remodeled gut microbiota with an enhanced anti-inflammatory capacity due to an increased induction of regulatory T cells (48).